|
Bayer Steps Back from Blackford, WCLC 2025, and the Berlin Lawsuit
September 8, 2025
|
|
|
|
|
Together with
|
|
|
|
“[T]his isn’t about adding AI. This is about owning the distribution layer. Whoever controls Blackford controls how dozens of startups reach hospitals. It’s not just a product. It’s a gatekeeper.”
|
|
Healthcare recruiter Jay Gurney, in a LinkedIn post on changes at Blackford Analysis.
|
|
|
Radiology leaders around the globe face the same challenge: keeping up with rising patient demand while managing costs. Discover how the SwiftMR MRI reconstruction solution from AIRS Medical is helping hospitals worldwide reduce scan times 50% while delivering sharper images radiologists can trust.
|
|
|
|
Pharmaceutical giant Bayer said it plans to deprioritize its investment in AI platform company Blackford Analysis as part of a general move away from the platform business. Bayer is also winding down its investment in Calantic Digital Solutions, the digital platform company it formed in 2022.
The move is a stunning turnaround for Blackford, which was founded in 2010 and was the first and perhaps most prominent of the digital AI platform companies.
- Bayer acquired Blackford in 2023, and operated it in parallel with Calantic, which also offered AI solutions in the platform format.
Platform AI companies have a simple value proposition: rather than buy AI algorithms from multiple individual developers, hospitals and imaging facilities contract with a single platform company and pick and choose the solutions they need.
- It’s a great idea, but platform providers face the same challenges as algorithm developers due to slower-than-expected AI clinical adoption.
Bayer’s move was confirmed by company representatives, who noted that personnel will be maintained to support the Blackford AI platform and fulfill existing contractual commitments.
- “Bayer has made the decision to deprioritize its digital platform business, which includes Blackford, and will discontinue offerings and services. Resources will be reinvested into growth areas that support healthcare institutions around the world, in alignment with customer needs,” the representative said.
And in a letter to customers obtained by The Imaging Wire, Blackford confirmed Bayer’s decision, stating that Blackford’s core team will remain in place led by COO James Holroyd during the transition.
- The company also said it would “discuss and facilitate opportunities to move existing Blackford contracts into direct deals with AI vendors, or alternate platform providers.”
Bayer’s withdrawal from the digital platform space includes the Calantic business, which Bayer formed three years ago to offer internally developed AI tools.
- At the time, industry experts postulated that contrast agent companies had an inside track for radiology AI thanks to their contracts to supply consumables to customers – a theory that in retrospect hasn’t borne fruit.
Speculation about Blackford’s fate burst into the public eye late last week with a detailed LinkedIn post by healthcare recruiter Jay Gurney, who explained that while Blackford has been successful – and is sitting on a “monster pipeline” of hospital deals – it’s simply not a great fit for a pharmaceutical company.
- Despite Bayer’s withdrawal, Blackford could make a good acquisition candidate for a company without a strong AI portfolio that wants to quickly boost its position.
The Takeaway
Bayer’s announcement that it’s winding down its Blackford and Calantic investments is sure to send shockwaves through the radiology AI industry, which is already struggling with slow clinical adoption and declining venture capital investment. The question is whether a white knight will ride to Blackford’s rescue.
|
|
Bring Your Radiology AI into Your Clinical Workflows
CARPL enables healthcare providers and researchers to develop, test, and deploy their own AI models within existing clinical infrastructure. From seamless data ingestion and de-identification to model training, packaging, and live deployment, CARPL provides an end-to-end environment tailored for radiology.
|
|
The Future of Fluoroscopy Is Here
The future of fluoroscopy has arrived. The LUMINOS Q.namix fluoroscopy systems from Siemens Healthineers are available on the U.S. market. Discover why they have already earned the prestigious Red Dot Design Award for intuitive design and user-centric innovation.
|
|
- Leonard Berlin Passes Away: Radiology legal expert Leonard Berlin, MD, passed away last week at the age of 90. Berlin was a practicing radiologist for 55 years and developed an interest in medical malpractice issues after his personal experience with the “Berlin Lawsuit,” a 1976 malpractice case in which he countersued the plaintiff’s attorney for filing for frivolous litigation. The jury found the attorney guilty after deliberating for 50 minutes. Berlin reflected on the experience in a 2021 JACR article.
- Lung Screening Benefits Older Adults: The IASLC’s World Conference on Lung Cancer started over the weekend, and a highlighted study points to the benefits of CT lung cancer screening for older people. U.K. researchers compared outcomes for patients with screen-detected cancer aged 55-74 to those aged 75-80, finding across 574 patients that all-cause mortality was worse in the older group (44% versus 34%). But four-year survival rates were similar for those treated with surgery (16% vs. 18%), showing screening is worthwhile for patients healthy enough for surgery.
- Sybil Lung AI’s Generalizability: In another talk from WCLC 2025, researchers tested the performance of the Sybil open-access AI algorithm in predicting lung cancer risk for minority groups. Sybil was first validated on a population that was over 90% White, but the new study covers over 2k scans in a population that was 62% Black and 13% Hispanic. Sybil predicted cancer with high AUC from year 1 to year 6 (0.94 through 0.79), showing the model’s high clinical generalizability to other patient groups.
- Early Results from Taiwan Lung Screening: Researchers presented data at WCLC 2025 on CT lung screening in Taiwan, where over 60% of lung cancer patients have no smoking history. In the first two years, 108.7k people got their first screening, with cancer detected in 1.3%. Non-smoking individuals with family histories of lung cancer had higher incidence than heavy smokers (1.7% vs. 0.8%), while screening reduced advanced-stage cancer for both groups (72% and 43%) with greater mortality reduction for those with family histories (67% vs. 36%).
- Visage Gets VA Nod for Cloud PACS: Visage Imaging received “authority to operate” status from the U.S. Department of Veterans Affairs for its Visage 7 cloud-based PACS software to be used within the VA’s Veterans Affairs Enterprise Cloud. The move will enable Visage to begin moving its on-premises PACS installations at VA sites to the VAEC’s cloud architecture. Visage plans to use the VAEC as a reference site for other VA facilities to migrate to the cloud.
- POCUS Reduces Hospital Length of Stay: Point-of-care ultrasound reduced hospital length of stay and hospitalization costs for patients with dyspnea (shortness of breath). In a new study in JAMA Network Open, researchers used Butterfly Network’s iQ3 POCUS probe in cardiopulmonary scans of 208 patients with dyspnea. Patients getting POCUS had a 30% reduction in length of stay (8.3 vs. 12 days), reducing stays a total of 246 days and saving $751.5k. But only 20% of POCUS evaluations were done by hospitalists, with the rest performed by sonographers.
- Contaminated Contrast Sickens Patients: Eight patients getting CT scans at a hospital in Belgium became sick – and several were hospitalized – after receiving contrast contaminated with bacteria. Hospital staff at AZ Sint-Blasius Hospital said the episode was caused by CT contrast contaminated with Klebsiella, a bacteria normally found in human stool. Bracco representatives confirmed that the company’s Iomeron agent was involved and it is investigating the incident, which it believes is isolated to just the eight patients scanned in a two-hour window. The source of the contamination is still unknown.
- Independent Rads Have Lowest Prices: A new study in JACR offers support for independent radiology groups, which have been slowly getting gobbled up by hospitals and private equity firms. Across 24.8k U.S. radiologists analyzed, hospital-employed radiologists had 43% higher professional fees than independent radiologists, while prices for PE-affiliated practices were 16% higher than independent practices. Ongoing practice consolidation could result in even higher imaging prices.
- Photon-Counting CT Race in China: As the U.S. market for photon-counting CT remains dominated by a single company (Siemens Healthineers), two firms are jockeying for position in China: United Imaging Healthcare and Neusoft Medical Systems. Both United Imaging and Neusoft reported getting Chinese regulatory approvals for their photon-counting scanners, United for its uCT Ultima and Neusoft for its NeuViz P10. Analysts see the approvals as a sign the Chinese government wants to promote domestically produced high-end CT for China’s massive market.
- United Imaging Grows Sales, Preps Products: United Imaging Healthcare grew its first-half revenue 13% thanks to sales of recently launched products in markets outside China, and it has more new launches on the way. For the period, United posted revenues of $846M with profit of $136M after excluding nonrecurring items. New first-half product launches included the uAngio AVIVA fluoroscopy system, and United is moving its uCT SiriuX CT scanner with a dual-wide gantry toward regulatory authorization in the U.S. and Europe.
- AIRS Gets Vizient Contract: AIRS Medical landed a contract to supply its SwiftMR software for MRI enhancement to the Vizient group purchasing organization. The contract is part of Vizient’s Innovative Technology Program, which gives Vizient members the opportunity to acquire products outside of competitive bid cycles, and Vizient made the award after a client-led council recommended the software. SwiftMR enables users to reduce scan times up to 50% by enhancing the image quality of exams acquired in shorter scanning times.
- Siemens Installs First Naeotom Alpha.Pro: Siemens Healthineers has installed the first Naeotom Alpha.Pro photon-counting CT scanner in the U.S., at University Hospitals in Cleveland. Siemens launched the dual-source Naeotom Alpha.Pro along with the single-source Naeotom Alpha.Prime at RSNA 2024 as part of an expansion of its CT offerings to make photon-counting CT available at lower price points.
- Telix Hits FDA Turbulence: Radiopharmaceutical developer Telix Pharmaceuticals continues to navigate regulatory turbulence with the FDA after the agency requested additional data on the company’s regulatory application for its Zircaix PET radiotracer for clear cell renal cell carcinoma, citing documentation deficiencies. The move triggered a stock drop and shareholder lawsuits, and came after the SEC hit Telix with a subpoena over one of its prostate cancer therapeutic candidates.
|
|
Echo AI – Revolution or Replacement?
How is AI echocardiography viewed by the clinicians who use it? Clinicians note that AI echo can enhance measurement accuracy and improve workflow efficiency, and share their secrets for successful implementation. Learn more on this page from Us2.ai.
|
|
AI-Powered Population Health
DeepHealth closed its acquisition of iCAD, a major step in DeepHealth’s vision to build the future of AI-powered population health. In this Imaging Wire Show, we talked to company executives Kees Wesdorp and Niccolo Stefani about the acquisition and their strategic roadmap.
|
|
Transform Imaging Data into Actionable Predictions
When you choose Quibim, you get more than a partner for detecting and diagnosing prostate cancer on MRI scans. Learn how they can help you transform imaging data into actionable predictions by booking a demo today.
|
|
- Unlocking Precision – A New Era of AI-Powered CT: AI is transforming diagnostic imaging, especially in CT. Discover how Prof. Davide Ippolito is leading the way with the Philips CT 5300 to pioneer ways to reduce radiation dose while improving image quality and set a new standard for the future of CT.
- AI-Assisted Fracture Detection: Gleamer’s BoneView AI solution helped radiologists detect fractures on radiographs of both adults and children in a meta-analysis of eight studies. Discover how it can help your practice today.
- The Evolution of PACS: PACS has become the backbone of efficiency in modern radiology, evolving into sophisticated enterprise-wide imaging solutions. Discover how Intelerad’s IntelePACS can deliver the innovation, intelligence, and flexibility your imaging strategy needs by booking a demo.
- 2 Questions about AI for Radiology Leaders: Are today’s radiology AI solutions solving the right problems? And are there other solutions available for AI of brain MRI? Read this article from SpinTech MRI to learn how their STAGE solution can optimize MRI utilization.
- Radiology Practice Models Explained: Radiologist Kurt Schoppe, MD, isn’t afraid to speak his mind, so listen to this episode of Medality’s Radiology Report Podcast to hear his take on healthcare policy and economics.
- Redefining Breast Imaging in the Enterprise Era: As breast imaging grows more complex, radiology teams need more than siloed tools. Join AGFA HealthCare and breast imaging and IT experts for this September 9 webinar about transforming breast imaging workflows in the enterprise imaging era.
- Introducing Voice-Controlled Interventional X-Ray: United Imaging’s uAngio AVIVA is the industry’s first intelligent voice-controlled interventional X-ray system, enabling interventional staff to keep their focus where it belongs: on the patient. Discover AVIVA’s advantages on this page.
- Revolutionize the Reading Experience: With intelligent automation and AI‑powered workflow, PowerScribe One from Microsoft allows radiologists to generate and communicate high‑quality, consistent reports – and get more done in less time.
- The Benefits of Structured Reporting: Kailo Medical hopes to revolutionize radiology with its structured reporting solutions. At SIIM 2025, we talked to Lauren Therriault and Denholm Rhys about the latest developments at the company and why structured reporting is a benefit to radiologists.
- Opportunistic Detection of CAC and Pulmonary Nodules: Achieve a newfound certainty of search for thoracic CT when using ClearRead CT from Riverain Technologies. It’s a natural addition for opportunistic CAC scoring and nodule detection, or as part of a CT lung cancer screening program.
- 5 Data Migrations Myths You May Still Believe: Many healthcare organizations fall victim to data migration myths that derail their efforts, waste valuable resources, and put their business at risk. Learn about five common myths and how they cost you in this article from Laitek, an Enlitic portfolio company.
- AI Acceleration without the Hype: The Visage AI Accelerator program is an innovation magnet – an end-to-end AI solution that bridges research and diagnostic imaging on the same, unified platform. Learn how Visage 7 provides synergistic, smart workflows and flawless third-party AI integration.
- Adding Digital Pathology to Enterprise Imaging: In this on-demand video from SIIM 2025 hosted by Mach7, watch as a panel of industry experts discusses how to add digital pathology images into a healthcare organization’s overall enterprise imaging strategy.
- Equitable Study Distribution with an Automated Worklist: Automated worklist functionality can distribute medical imaging studies more equitably than manual study selection. Discover how Merge Workflow Orchestrator enabled one institution to achieve balance in this downloadable white paper.
|
|
|
|
|
